Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 7/20 | 0.52 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.44 |
| ▸ | F2 | P00734 | 5/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27470745 | 0.86 | F10 (0.52) | F10CYP2A13F2KDM4EPOLB | |
| SCHEMBL6590808 | 0.84 | F10 (0.51) | F10CYP2A13F2L3MBTL1LMNA | |
| SCHEMBL6600222 | 0.84 | F10 (0.53) | F10CYP2A13F2KDM4EPOLB | |
| SCHEMBL6601695 | 0.83 | F10 (0.53) | F10F2SMN1; SMN2ADORA1KDM4E | |
| SCHEMBL6595675 | 0.82 | F10 (0.52) | F10CYP2A13F2KDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL6590659 | 0.82 | F10 (0.53) | F10F2SMN1; SMN2ADORA1KDM4E | |
| SCHEMBL4078686 | 0.71 | GPR35 (0.42) | L3MBTL1KDM4EALDH1A1POLB | |
| SCHEMBL6596838 | 0.71 | GPR35 (0.42) | L3MBTL1KDM4EPOLB | |
| SCHEMBL6594051 | 0.70 | F10 (0.51) | F10CYP2A13F2SMN1; SMN2 | |
| SCHEMBL6592233 | 0.69 | F10 (0.54) | F10F2LMNAADORA1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1040108-B1 | ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS | SCHERING AG (DE) | 2004-02-25 | — | — | EP | disclosed |
| US-6498185-B1 | ENZYME FACTOR XA INHIBITORS | BERLEX LABORATORIES, INC. | 2002-12-24 | — | — | US | disclosed |
| US-6380221-B1 | FOR THERAPY OF DISEASE-STATES CHARACTERIZED BY THROMBOTIC ACTIVITY | BERLEX LABORATORIES, INC. | 2002-04-30 | — | — | US | disclosed |
| US-6140351-A | FOR TREATING THROMBOSIS | BERLEX LABORATORIES, INC. (US) | 2000-10-31 | — | — | US | disclosed |
| EP-1040108-A1 | ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS | SCHERING AKTIENGESELLSCHAFT (DE) | 2000-10-04 | — | — | EP | disclosed |
| WO-1999032477-A1 | ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-07-01 | — | — | WO | disclosed |